Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    January 2022
  1. ADJORLOLO S, Mensah G, Badzi CD
    Psychosis risk among pregnant women in Ghana.
    PLoS One. 2022;17:e0263011.
    PubMed     Abstract available


  2. ABED-ESFAHANI P, Darwin BC, Howard D, Wang N, et al
    Evaluation of deep convolutional neural networks for in situ hybridization gene expression image representation.
    PLoS One. 2022;17:e0262717.
    PubMed     Abstract available


  3. DHUNGANA S, Tulachan P, Chapagai M, Pant SB, et al
    Internalized stigma in patients with schizophrenia: A hospital-based cross-sectional study from Nepal.
    PLoS One. 2022;17:e0264466.
    PubMed     Abstract available


  4. OKAZAKI S, Boku S, Watanabe Y, Otsuka I, et al
    Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia.
    PLoS One. 2022;17:e0265738.
    PubMed     Abstract available


  5. JIANG Z, Luskus M, Seyedi S, Griner EL, et al
    Utilizing computer vision for facial behavior analysis in schizophrenia studies: A systematic review.
    PLoS One. 2022;17:e0266828.
    PubMed     Abstract available


  6. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    PubMed     Abstract available


  7. LIAN L, Kim DD, Procyshyn RM, Cazares D, et al
    Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.
    PLoS One. 2022;17:e0267808.
    PubMed     Abstract available


  8. TOYAMA M, Takasaki Y, Branko A, Kimura H, et al
    Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels.
    PLoS One. 2022;17:e0268321.
    PubMed     Abstract available


  9. ALGUMAEI AH, Algunaid RF, Rushdi MA, Yassine IA, et al
    Feature and decision-level fusion for schizophrenia detection based on resting-state fMRI data.
    PLoS One. 2022;17:e0265300.
    PubMed     Abstract available


  10. FAULKNER SM, Drake RJ, Ogden M, Gardani M, et al
    A mixed methods expert opinion study on the optimal content and format for an occupational therapy intervention to improve sleep in schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0269453.
    PubMed     Abstract available


  11. ERSHOVA ES, Shmarina GV, Martynov AV, Zakharova NV, et al
    NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.
    PLoS One. 2022;17:e0269130.
    PubMed     Abstract available


  12. ADEME M, Kebede T, Teferra S, Alemayehu M, et al
    Is latent Toxoplasma gondii infection associated with the occurrence of schizophrenia? A case-control study.
    PLoS One. 2022;17:e0270377.
    PubMed     Abstract available


  13. BARBIC D, Whyte M, Sidhu G, Luongo A, et al
    One-year mortality of emergency department patients with substance-induced psychosis.
    PLoS One. 2022;17:e0270307.
    PubMed     Abstract available


  14. CHIEN TY, Chern JS, Wang SP, Yang Y, et al
    Effects of multitask training on cognition and motor control in people with schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0264745.
    PubMed     Abstract available


  15. YOSHIKAWA A, Kushima I, Miyashita M, Suzuki K, et al
    Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype.
    PLoS One. 2022;17:e0270506.
    PubMed     Abstract available


  16. AKENA D, Semeere A, Kadama P, Mwesiga EK, et al
    Feasibility of conducting a pilot randomized control trial of a psycho-education intervention in patients with a first episode psychosis in Uganda-A study protocol.
    PLoS One. 2022;17:e0268493.
    PubMed     Abstract available


  17. GARGANO G, Caletti E, Perlini C, Turtulici N, et al
    Language production impairments in patients with a first episode of psychosis.
    PLoS One. 2022;17:e0272873.
    PubMed     Abstract available


  18. WYNN JK, McCleery A, Novacek DM, Reavis EA, et al
    The impact of the COVID-19 pandemic on mental health and functional outcomes in Veterans with psychosis or recent homelessness: A 15-month longitudinal study.
    PLoS One. 2022;17:e0273579.
    PubMed     Abstract available


  19. KHATTAK MI, Dikomitis L, Khan MF, Haq MU, et al
    Patients' and healthcare professionals' perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study.
    PLoS One. 2022;17:e0273286.
    PubMed     Abstract available


  20. KADRA-SCALZO G, Fonseca de Freitas D, Agbedjro D, Francis E, et al
    A predictor model of treatment resistance in schizophrenia using data from electronic health records.
    PLoS One. 2022;17:e0274864.
    PubMed     Abstract available


  21. AL-HAKEIM HK, Al-Musawi AF, Al-Mulla A, Al-Dujaili AH, et al
    The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.
    PLoS One. 2022;17:e0275839.
    PubMed     Abstract available


  22. RAMOS-MASTACHE D, Mondragon-Maya A, Liemburg EJ, Enriquez-Geppert S, et al
    Understanding the relationship between apathy, cognition and functional outcome in schizophrenia: The significance of an ecological assessment.
    PLoS One. 2022;17:e0277047.
    PubMed     Abstract available


  23. JONES CJ, Hazell CM, Hayward M, Pandey A, et al
    Caring for Carers (C4C): Results from a feasibility randomised controlled trial of positive written disclosure for older adult carers of people with psychosis.
    PLoS One. 2022;17:e0277196.
    PubMed     Abstract available


  24. RAZZAK RA, Jahrami H, Husni M, Ali ME, et al
    Perceptual visual dependence for spatial orientation in patients with schizophrenia.
    PLoS One. 2022;17:e0278718.
    PubMed     Abstract available


  25. AL-NEMA M, Gaurav A, Lee MT, Okechukwu P, et al
    Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia.
    PLoS One. 2022;17:e0278216.
    PubMed     Abstract available


  26. JOHNSON T, Saatci D, Handunnetthi L
    Maternal immune activation induces methylation changes in schizophrenia genes.
    PLoS One. 2022;17:e0278155.
    PubMed     Abstract available


    January 2021
  27. HINOJOSA-MARQUES L, Monsonet M, Kwapil TR, Barrantes-Vidal N, et al
    The impact of family environment on self-esteem and symptoms in early psychosis.
    PLoS One. 2021;16:e0249721.
    PubMed     Abstract available


  28. MAKI S, Nagai K, Ando S, Tamakoshi K, et al
    Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study.
    PLoS One. 2021;16:e0250771.
    PubMed     Abstract available


  29. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available


  30. HAYASHI N, Igarashi Y, Harima H
    Delusion progression process from the perspective of patients with psychoses: A descriptive study based on the primary delusion concept of Karl Jaspers.
    PLoS One. 2021;16:e0250766.
    PubMed     Abstract available


  31. ROSEN DL, Travers D
    Emergency department visits among patients transported by law enforcement officers.
    PLoS One. 2021;16:e0244679.
    PubMed     Abstract available


  32. KIM K, Duc NT, Choi M, Lee B, et al
    EEG microstate features for schizophrenia classification.
    PLoS One. 2021;16:e0251842.
    PubMed     Abstract available


  33. KRONBICHLER L, Stelzig-Scholer R, Lenger M, Weber S, et al
    Preserved intention understanding during moral judgments in schizophrenia.
    PLoS One. 2021;16:e0251180.
    PubMed     Abstract available


  34. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    PubMed     Abstract available


  35. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    PubMed     Abstract available


  36. KURUKGY JL, Bourgin J, Benoit JP, Guessoum SB, et al
    Implementing organicity investigations in early psychosis: Spreading expertise.
    PLoS One. 2021;16:e0252610.
    PubMed     Abstract available


  37. NOROVSAMBUU O, Tsend-Ayush A, Lkhagvasuren N, Jav S, et al
    Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.
    PLoS One. 2021;16:e0252831.
    PubMed     Abstract available


  38. SCHILLING TM, Bossert M, Konig M, Wirtz G, et al
    Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
    PLoS One. 2021;16:e0254695.
    PubMed     Abstract available


  39. HUCKLE C, Lemmel F, Johnson S
    Experiences of friendships of young people with first-episode psychosis: A qualitative study.
    PLoS One. 2021;16:e0255469.
    PubMed     Abstract available


  40. SHOR O, Glik A, Yaniv-Rosenfeld A, Valevski A, et al
    EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline.
    PLoS One. 2021;16:e0255529.
    PubMed     Abstract available


  41. JUNG YS, Kim YE, Go DS, Yoon SJ, et al
    The prevalence, incidence, and admission rate of diagnosed schizophrenia spectrum disorders in Korea, 2008-2017: A nationwide population-based study using claims big data analysis.
    PLoS One. 2021;16:e0256221.
    PubMed     Abstract available


  42. SHIMIZU J, Kuwata H, Kuwata K
    Differences in fractal patterns and characteristic periodicities between word salads and normal sentences: Interference of meaning and sound.
    PLoS One. 2021;16:e0247133.
    PubMed     Abstract available


  43. DUTRA-TAVARES AC, Manhaes AC, Semeao KA, Maia JG, et al
    Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
    PLoS One. 2021;16:e0257986.
    PubMed     Abstract available


  44. MARTIN J, Asjadi K, Hubbard L, Kendall K, et al
    Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    PLoS One. 2021;16:e0248254.
    PubMed     Abstract available


  45. DOYEN S, Taylor H, Nicholas P, Crawford L, et al
    Hollow-tree super: A directional and scalable approach for feature importance in boosted tree models.
    PLoS One. 2021;16:e0258658.
    PubMed     Abstract available


  46. DESALEGN D, Abdu Z, Hajure M
    Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study.
    PLoS One. 2021;16:e0261154.
    PubMed     Abstract available


  47. WOLDEKIDAN NA, Mohammed AS, Degu A, Tadiwos Y, et al
    Prevalence of metabolic syndrome and associated factors among psychiatric patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    PLoS One. 2021;16:e0256195.
    PubMed     Abstract available


  48. SAKURAI K, Itou T, Morita M, Kasahara E, et al
    Effects of Importin alpha1/KPNA1 deletion and adolescent social isolation stress on psychiatric disorder-associated behaviors in mice.
    PLoS One. 2021;16:e0258364.
    PubMed     Abstract available


  49. ZANDER-SCHELLENBERG T, Kuhn SAK, Moller J, Meyer AH, et al
    Is intuition allied with jumping to conclusions in decision-making? An intensive longitudinal study in patients with delusions and in non-clinical individuals.
    PLoS One. 2021;16:e0261296.
    PubMed     Abstract available


  50. LEE GS, Zhang J, Wu Y, Zhou Y, et al
    14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons.
    PLoS One. 2021;16:e0261791.
    PubMed     Abstract available


  51. HAYAKAWA T, Terahara M, Fujito NT, Matsunaga T, et al
    Lower promoter activity of the ST8SIA2 gene has been favored in evolving human collective brains.
    PLoS One. 2021;16:e0259897.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: